|
AKRO
|
Akero Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ALGS
|
Aligos Therapeutics, Inc.
|
US
|
NASDAQ
|
|
BLTE
|
Belite Bio, Inc.
|
US
|
NASDAQ
|
|
ETNB
|
89bio, Inc.
|
US
|
NASDAQ
|
|
GALT
|
Galectin Therapeutics Inc.
|
US
|
NASDAQ
|
|
GLS
|
Gelesis Holdings, Inc.
|
US
|
NYSE
|
|
GLTO
|
Galecto, Inc.
|
US
|
NASDAQ
|
|
GNFT
|
GENFIT S.A.
|
US
|
NASDAQ
|
|
ICPT
|
Intercept Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
IONS
|
Ionis Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
IVA
|
Inventiva S.A.
|
US
|
NASDAQ
|
|
MTCR
|
Metacrine, Inc.
|
US
|
NASDAQ
|
|
NGM
|
NGM Biopharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
PLRX
|
Pliant Therapeutics, Inc.
|
US
|
NASDAQ
|
|
TERN
|
Terns Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
VKTX
|
Viking Therapeutics, Inc.
|
US
|
NASDAQ
|
|
IMC
|
Immuron Limited
|
AU
|
ASX
|
|
PXS
|
Pharmaxis Ltd.
|
AU
|
ASX
|
|
VBS
|
Vectus Biosystems Ltd
|
AU
|
ASX
|
|
337
|
Corbus Pharmaceuticals Holding
|
DE
|
F
|